A lncRNA-immune checkpoint-related gene signature predicts metastasis-free survival in prostate adenocarcinoma.
Translational andrology and urology（2022）
摘要
Our results provide new targets for predicting tumor metastasis in PRAD and treating patients with metastatic PRAD.
更多查看译文
关键词
Metastatic prostate adenocarcinoma (metastatic PRAD),immune checkpoint genes (ICGs),long non-coding RNA (lncRNA)
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要